DexCom, Inc. (DXCM) Misses Q3 EPS by 3c

Go back to DexCom, Inc. (DXCM) Misses Q3 EPS by 3c

Canaccord Genuity Calls DexCom (DXCM) Quarter Solid, Says Momentum Building

November 2, 2012 1:26 PM EDT

Canaccord Genuity maintained a Buy rating on DexCom (NASDAQ: DXCM) with an adjusted price target of $19.00 (from $20).

Commenting on the companys quarterly results, analyst William J. Plovanic said "Net, net we believe Q3/12 was a solid quarter with DexCom continuing to build... More